Loading...
Loading...
India's clopidogrel imports from BRAZIL total $316 across 1 shipments from 1 foreign suppliers. DERMA & DERMO COM. PRODS. DERM leads with $316 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include CYMA LIFE SCIENCES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for clopidogrel — a concentrated sourcing relationship with select suppliers from BRAZIL.

DERMA & DERMO COM. PRODS. DERM is the leading Clopidogrel supplier from BRAZIL to India, with import value of $316 across 1 shipments. The top 5 suppliers — DERMA & DERMO COM. PRODS. DERM — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DERMA & DERMO COM. PRODS. DERM | $316 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CYMA LIFE SCIENCES PRIVATE LIMITED | $316 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Clopidogrel suppliers from BRAZIL to India include DERMA & DERMO COM. PRODS. DERM. The leading supplier is DERMA & DERMO COM. PRODS. DERM with import value of $316 USD across 1 shipments. India imported Clopidogrel worth $316 USD from BRAZIL in total across 1 shipments.
India imported Clopidogrel worth $316 USD from BRAZIL across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Clopidogrel sourced from BRAZIL include CYMA LIFE SCIENCES PRIVATE LIMITED. The largest buyer is CYMA LIFE SCIENCES PRIVATE LIMITED with $316 in imports across 1 shipments.
The total value of Clopidogrel imports from BRAZIL to India is $316 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists